Skip to main content
Home » Reports » Healthcare » Advanced Drug Delivery Market
ReesrachMoz Brochure Icon

Global Advanced Drug Delivery Market Analysis and Forecast 2020-2030

Report ID:640Healthcare288 pages

Advanced Drug Delivery Market Statistics

The global advanced drug delivery market is predicted to witness a staggering expansion of at a CAGR of 16.0% during the forecast period between 2020 to 2030.

The estimated value of the advanced drug delivery market in 2020 was USD 44, 029.59mn and as per predictions, it might reach estimated valuation of USD 1,95, 132.45mn by 2030.

Advanced drug delivery aims at releasing or administering drugs at specific area or the body site instead of traditional methods of treatment.

Growing chronic diseases is one of the major factors driving the global advanced drug delivery market to expand during the forecast period.

Drivers and Restraints

The rising cases of Cancer, TB, Diabetes, Cardiovascular diseases are expected to drive the advanced drug delivery market in the coming years.

With the technological advancement in the medical sector, the advanced drug delivery market is expected to grow in the following years.

Wide range of benefits such as reduced dosing, increased efficacy, therapeutic site action, etc., are expected to bolster the demand for advanced drug delivery over the next few years.

Growing expenditure in research and development and healthcare is likely to boost the demand for the global advanced drug delivery in the coming years.

However, stringent rules and regulations, high drug development cost, costly treatments are expected to hinder the global advanced drug delivery market during the forecast period.

Nevertheless, the recent advances in genomics and development of new biopharmaceuticals are expected to boost the growth in the global advanced drug delivery market.

Global Advanced Drug Delivery Market Share By Region Type

Opportunities and Trends

The growing number of chronic diseases such as cancer is anticipated to drive the global advanced delivery market.

The growing research and development in next-generation drug delivery technologies is expected to bolster the global advanced drug delivery market during the forecast period.

The on-going research in genomics and Nano technologies is expected to bring a paradigm shift in advanced drug delivery, thus paving the way for the staggering growth over the next few years.

using molecular engineering, the advanced drug delivery aims to remove absorption challenges at target sites of the body is projected to boost the growth in the global advanced delivery market.

The development of nanoparticles and the continued efforts to control the release of drug in order to provide efficacy and enhanced therapeutic effects is anticipated to bolster the growth opportunities of the global advanced drug delivery market.

The improved lifestyle of patients by offering them less frequent dosing and improved efficacy is expected to drive the advanced drug delivery market to grow in the following years.

Many drugs delivery systems are underway, which may nudge the global advanced drug delivery market to grow during the forecast period.

The emergence of gene therapy and new bioactive materials are gaining traction in the global advanced drug delivery market, which may further push the market towards expansion in the following years.

Product Segment Overview

The global advanced drug delivery market is bifurcated into three major categories such as delivery mode, carrier mode, and end-users.

However, of all these, in terms of carrier type, the nanoparticles type is expected to hold a lion’s share in the global advanced drug delivery market.

The growth in the region can be attributed to higher efficacy and lesser toxicity in comparison with the traditional methods of the treatment.

In the end users’ segment, hospital sector is expected to hold a lion’s share in the global advanced drug delivery market, the growth in the region can be attributed to high demand for in patients and out patients.

In 2020, the clinic segment held a largest share in the global advanced drug delivery market, owing to increased patient of neurology, orthopedic, etc.

Regional Market Overview

On the basis of region, the global advanced drug delivery market is predicted by dominated by Asia Pacific, owing to increased expenditure in drug development area in the pharmaceuticals and research and development in the biotechnology during the forecast period.

North America dominated the global advanced drug delivery market in the year 2020, owing to robust infrastructure for research and development and advanced technologies.

Competitive Landscape

The global advanced drug delivery market is highly competitive due to the presence of many players in the market. The market players are strategizing on mergers and collaborations, which further is expected to help with expansion of the advanced drug delivery market in the following years.

Some of the current players in the global advanced drug delivery include-

  • AstraZeneca
  • NeXstar Pharmaceuticals, Inc
  • West Pharmaceutical Services, Inc
  • Novartis International AG
  • 3M
  • Sequus Pharmaceuticals Inc

Delivery Mode Disposition (USD Revenue in Millions)

  • Oral drug delivery
  • Pulmonary drug delivery
  • Transdermal drug delivery
  • Parenteral drug delivery

Carrier Type Disposition (USD Revenue in Millions)

  • Liposomes
  • Nanoparticles
  • Microspheres
  • Monoclonal antibodies
  • Others

End Users Disposition (USD Revenue in Millions)

  • Hospitals
  • Specialized clinics
  • Clinical Research & Development Centers

Regional Disposition         

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions (FAQ’s)

  1. What are the growth opportunities in the advanced drug delivery market?
  2. What are the determinants for growth in the global advanced drug delivery market?
  3. Which segment of the end users will dominate the advanced drug delivery market during the forecast period?
  4. How is the competition in the global advanced drug delivery market and what are the market expansion strategies that are market players aiming at?
  5. What would be the market size in the coming years and how well it is expected to grow during the forecast period?
  6. Which region in the global advanced drug delivery market is expected to thrive during the forecast years and why?
  7. What are the regions that would witness a slow growth in the coming days?

Table Of Content

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations

2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics

4. Global Advanced Drug Delivery Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis

5. Global Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Delivery Mode Disposition
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Delivery Mode Disposition, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Delivery Mode Disposition, 2022-2032
5.3.1. Oral drug delivery
5.3.2. Pulmonary drug delivery
5.3.3. Transdermal drug delivery
5.3.4. Parenteral drug delivery
5.4. Y-o-Y Growth Trend Analysis By Delivery Mode Disposition, 2017-2021
5.5. Absolute $ Opportunity Analysis By Delivery Mode Disposition, 2022-2032

6. Global Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Carrier Type Disposition
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Carrier Type Disposition, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Carrier Type Disposition, 2022-2032
6.3.1. Liposomes
6.3.2. Nanoparticles
6.3.3. Microspheres
6.3.4. Monoclonal antibodies
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By Carrier Type Disposition, 2017-2021
6.5. Absolute $ Opportunity Analysis By Carrier Type Disposition, 2022-2032

7. Global Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By End Users Disposition
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End Users Disposition, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End Users Disposition, 2022-2032
7.3.1. Hospitals
7.3.2. Specialized clinics
7.3.3. Clinical Research & Development Centers
7.4. Y-o-Y Growth Trend Analysis By End Users Disposition, 2017-2021
7.5. Absolute $ Opportunity Analysis By End Users Disposition, 2022-2032

8. Global Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region

9. North America Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Delivery Mode Disposition
9.2.3. By Carrier Type Disposition
9.2.4. By End Users Disposition
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Delivery Mode Disposition
9.3.3. By Carrier Type Disposition
9.3.4. By End Users Disposition
9.4. Key Takeaways

10. Latin America Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Chile
10.2.1.5. Peru
10.2.1.6. Rest of Latin America
10.2.2. By Delivery Mode Disposition
10.2.3. By Carrier Type Disposition
10.2.4. By End Users Disposition
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Delivery Mode Disposition
10.3.3. By Carrier Type Disposition
10.3.4. By End Users Disposition
10.4. Key Takeaways

11. Europe Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Delivery Mode Disposition
11.2.3. By Carrier Type Disposition
11.2.4. By End Users Disposition
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Delivery Mode Disposition
11.3.3. By Carrier Type Disposition
11.3.4. By End Users Disposition
11.4. Key Takeaways

12. East Asia Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Delivery Mode Disposition
12.2.3. By Carrier Type Disposition
12.2.4. By End Users Disposition
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Delivery Mode Disposition
12.3.3. By Carrier Type Disposition
12.3.4. By End Users Disposition
12.4. Key Takeaways

13. South Asia Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Malaysia
13.2.1.4. Indonesia
13.2.1.5. Rest of South Asia
13.2.2. By Delivery Mode Disposition
13.2.3. By Carrier Type Disposition
13.2.4. By End Users Disposition
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Delivery Mode Disposition
13.3.3. By Carrier Type Disposition
13.3.4. By End Users Disposition
13.4. Key Takeaways

14. Oceania Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Delivery Mode Disposition
14.2.3. By Carrier Type Disposition
14.2.4. By End Users Disposition
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Delivery Mode Disposition
14.3.3. By Carrier Type Disposition
14.3.4. By End Users Disposition
14.4. Key Takeaways

15. MEA Advanced Drug Delivery Market Analysis 2017-2021 and Forecast 2022-2032, By Country
15.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
15.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
15.2.1. By Country
15.2.1.1. GCC
15.2.1.2. Rest of MEA
15.2.2. By Delivery Mode Disposition
15.2.3. By Carrier Type Disposition
15.2.4. By End Users Disposition
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Delivery Mode Disposition
15.3.3. By Carrier Type Disposition
15.3.4. By End Users Disposition
15.4. Key Takeaways

16. Key Countries Advanced Drug Delivery Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Delivery Mode Disposition
16.1.2.2. By Carrier Type Disposition
16.1.2.3. By End Users Disposition
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Delivery Mode Disposition
16.2.2.2. By Carrier Type Disposition
16.2.2.3. By End Users Disposition
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Delivery Mode Disposition
16.3.2.2. By Carrier Type Disposition
16.3.2.3. By End Users Disposition
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Delivery Mode Disposition
16.4.2.2. By Carrier Type Disposition
16.4.2.3. By End Users Disposition
16.5. Argentina
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Delivery Mode Disposition
16.5.2.2. By Carrier Type Disposition
16.5.2.3. By End Users Disposition

17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1.  By Regional
17.3.2.  By Delivery Mode Disposition
17.3.3.  By Carrier Type Disposition
17.3.4.  By End Users Disposition

18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. AstraZeneca
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.1.5.2. Product Strategy
18.1.1.5.3. Channel Strategy
18.1.2. NeXstar Pharmaceuticals, Inc
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.2.5.2. Product Strategy
18.1.2.5.3. Channel Strategy
18.1.3. West Pharmaceutical Services, Inc
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.3.5.2. Product Strategy
18.1.3.5.3. Channel Strategy
18.1.4. Novartis International AG
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.4.5.2. Product Strategy
18.1.4.5.3. Channel Strategy
18.1.5. 3M
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.5.5.2. Product Strategy
18.1.5.5.3. Channel Strategy
18.1.6. Sequus Pharmaceuticals Inc
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region)
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.6.5.2. Product Strategy
18.1.6.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Request Free Sample

Hidden
Company logos Strips